Two years ago, in October 2018, Forbes contributor Neil Sahota, a United Nations artificial intelligence adviser and UC Irvine professor, warned that transhumanism is fast approaching—likely faster than you think.1 “In the past few years, there has been considerable discussion around the idea we are slowly merging with our technology, that we are becoming transhuman, with updated abilities, including enhanced intelligence, strength, and awareness,” Sahota writes.
The goal of the transhumanist movement, or “Human 2.0,” is to transcend biology into technology. Or, as Dr. Carrie Madej explains in the video above, to meld human biology with technology and artificial intelligence.
According to Dr. Madej, right now, today, we may be standing at the literal crossroads of transhumanism, thanks to the fast approaching release of one or more mRNA COVID-19 vaccines.
The World Health Organization (WHO) is helping coordinate a massive effort to develop and distribute COVID-19 vaccines around the world — and in a characteristic move, the Trump administration decided not to help out.
An impressive 156 countries — 64 of them high-income nations including Australia and Japan — have already signed on to the initiative, called the COVID-19 Vaccines Global Access (COVAX) Facility, which hopes to distribute 2 billion vaccine doses by the end of 2021, Ars Technica reports. Dozens more are expected to join in the coming days, but notable absences include the U.S., China, and Russia.
It’s a conundrum for vaccine researchers and producers alike: what’s the best strategy for vaccinating against a deadly virus if the immune system will forget how to protect itself against it a year later?
Recent research that suggests that novel coronavirus immunity doesn’t last very long have thrown a wrench in the global plans to develop and roll out a vaccine. The duration of protective immunity, which is how long a person is naturally protected from the coronavirus following an infection, is believed to be anywhere between four to twelve months at the moment, based on current research.
Since the coronavirus which causes COVID-19 is so new to science, it is still impossible to study long-term immunity using human data just yet. However, as Salon has previously reported, a conservative prediction suggests that a previously-infected person is immune to the coronavirus for at least three months. More recently, researchers published a study in the scientific journal Nature Medicine suggesting that people who contract the novel coronavirus and then become immune may stay that way for up to twelve months, based on studying four different seasonal coronaviruses.
WASHINGTON, May 19, 2016 /PRNewswire/ — The examination of autopsied brain tissues from patients who died of serious neurological conditions has revealed that many tick-borne infections, such as Lyme disease, go undiagnosed and untreated. Board-certified pathologist, Alan B. MacDonald, MD, says his research shows “tick infections are not easily detected with routine tests, nor are they easily cured with short courses of antibiotics.”
VLA Comment: The United States scientist has been working for years on GAIN OF FUNCTION (This includes Fauci) with the Chinese. Gain of Function is taking a animal virus that does not jump species and manipulate it to infect another species, namely human being.